Novel Use of 308-nm Excimer Laser to Treat a Primary Cutaneous CD30+ Lymphoproliferative Nodule

April 2007 | Volume 6 | Issue 4 | Case Reports | 440 | Copyright © April 2007

John L. Meisenheimer MD

CD30+ cutaneous lymphoproliferative disorders, the second most common cutaneous T cell lymphoma after mycosis fungoides, represent a spectrum of conditions ranging from lymphomatoid papulosis to borderline CD30+ lesions to anaplastic large-cell lymphoma. We report the case of a solitary cutaneous CD30+ lymphoproliferative nodule that was successfully treated with a 308-nm excimer laser. Our findings suggest that the 308-nm excimer laser may be a safe, effective, and welltolerated therapy for primary localized CD30+ cutaneous lymphoproliferative lesions.